Utilizzo del plasma ricco di piastrine (PRP) nel trattamento delle lesioni muscolari acute

Title

Code

PRPmusc

Type

Sperimentale

Start Year

2026

Status

In Corso

Principal Investigator

051-6366828

fabio.vita@ior.it

Vita Fabio, MD

1st Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica I

Director

Faldini Cesare, MD

Go to the details >>

Documents and Videos attachament

Attachment

Informazioni sul trattamento dei dati personali e particolari - prot. PRPmusc

Wednesday 14 January 2026, 16:33

informativa_dati_PRPmusc_v.1.0.pdf

Attachment

Nulla osta alla conduzione dello studio prot. PRPmusc

Wednesday 14 January 2026, 16:32

PG0000541_2026_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Utilizzo del plasma ricco di piastrine (PRP) nel trattamento delle lesioni muscolari acute

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Utilizzo del plasma ricco di piastrine (PRP) nel trattamento delle lesioni muscolari acute

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in